• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

顺铂对儿童难治性恶性肿瘤的作用

[Effects of cis-DDP in children with refractory malignant tumors].

作者信息

Nakadate H, Kobayashi R, Nishi M, Hatae Y, Takeda T, Uchino J, Hirama T, Kobayashi H

出版信息

Gan To Kagaku Ryoho. 1986 Mar;13(3 Pt 1):598-603.

PMID:3954383
Abstract

Eighteen children with refractory malignant tumors were treated with cis-DDP. They included 10 neuroblastomas, 2 rhabdomyosarcomas, and one each of hepatoblastoma, yolk sac tumor, osteosarcoma and pinealoma. Of 7 cases treated only with cis-DDP, 2 were NC, 6 PD and none were CR or PR. Of 11 cases treated with cis-DDP combined with other agents, 7 were PR, 2 NC, 2 PD and none were CR. The major side effect of cis-DDP was renal toxicity, but this was not serious and only transient. Three cases were treated with the continuous intra-arterial infusion method. These included 2 neuroblastomas and one yolk sac tumor. This treatment was therefore highly effective for children with malignant tumors, and few side effects were observed.

摘要

18例难治性恶性肿瘤患儿接受了顺铂治疗。其中包括10例神经母细胞瘤、2例横纹肌肉瘤,以及各1例肝母细胞瘤、卵黄囊瘤、骨肉瘤和松果体瘤。仅接受顺铂治疗的7例中,2例病情稳定(NC),6例病情进展(PD),无完全缓解(CR)或部分缓解(PR)者。接受顺铂联合其他药物治疗的11例中,7例部分缓解(PR),2例病情稳定(NC),2例病情进展(PD),无完全缓解(CR)者。顺铂的主要副作用是肾毒性,但并不严重,且只是短暂性的。3例采用持续动脉内灌注法治疗。其中包括2例神经母细胞瘤和1例卵黄囊瘤。因此,这种治疗方法对患有恶性肿瘤的儿童非常有效,且观察到的副作用很少。

相似文献

1
[Effects of cis-DDP in children with refractory malignant tumors].顺铂对儿童难治性恶性肿瘤的作用
Gan To Kagaku Ryoho. 1986 Mar;13(3 Pt 1):598-603.
2
[Effect of cis-platinum in neuroblastoma].[顺铂在神经母细胞瘤中的作用]
Gan To Kagaku Ryoho. 1985 Jan;12(1):147-50.
3
Evaluation of cis-dichlorodiammineplatinum(II) in children with advanced malignant diseases: Southwest Oncology Group Studies.顺二氯二氨铂(II)在晚期恶性疾病儿童中的评估:西南肿瘤协作组研究
Cancer Treat Rep. 1979 Sep-Oct;63(9-10):1611-4.
4
Clinical response and toxicity with cis-dichlorodiammineplatinum(II) in children.
Cancer Treat Rep. 1977 Aug;61(5):835-9.
5
[Clinical evaluation of cisplatin in children with malignant solid tumors. Pediatric Cisplatin Study Group].[顺铂用于儿童恶性实体瘤的临床评估。儿童顺铂研究组]
Gan To Kagaku Ryoho. 1987 Nov;14(11):3083-90.
6
[BAEPs of children with malignant tumor undergoing cisplatin treatment].[接受顺铂治疗的恶性肿瘤患儿的脑干听觉诱发电位]
Gan To Kagaku Ryoho. 1986 Mar;13(3 Pt 1):616-9.
7
Continuous or repeated prolonged cisplatin infusions in children: a prospective study on ototoxicity, platinum concentrations, and standard serum parameters.儿童顺铂持续或重复长时间输注:一项关于耳毒性、铂浓度及标准血清参数的前瞻性研究。
Pediatr Blood Cancer. 2006 Aug;47(2):183-93. doi: 10.1002/pbc.20673.
8
Phase II trial of topotecan administered as 72-hour continuous infusion in children with refractory solid tumors: a collaborative Pediatric Branch, National Cancer Institute, and Children's Cancer Group Study.拓扑替康以72小时持续输注方式给药用于难治性实体瘤患儿的II期试验:国立癌症研究所儿科分部和儿童癌症研究组的一项合作研究
Clin Cancer Res. 1998 Feb;4(2):357-60.
9
Pharmacokinetic evaluation of cisplatin in children with malignant solid tumors: a phase II study.顺铂在儿童恶性实体瘤中的药代动力学评估:一项II期研究。
Cancer Treat Rep. 1981 Nov-Dec;65(11-12):1021-6.
10
[Intra-arterial infusion of CDDP in advanced gastrointestinal cancer (combination of general chemotherapy)].
Gan To Kagaku Ryoho. 1986 Mar;13(3 Pt 1):586-9.